Silverback Therapeutics terminates Seattle HQ lease effective Dec 31, 2022

ARS Pharmaceuticals, Inc.

Terminated lease for ~19,829 sq ft at 500 Fairview Ave N, Seattle; lease expires Dec 31, 2022.
No termination fee payable to landlord; lease end contingent on new tenant lease now executed.
Tenant remains responsible for all rent through Dec 31, 2022; must surrender premises in good condition.
Silverback grants temporary license to new tenant (Approved Licensee) for premises before termination.
Company discloses it is undergoing a corporate merger; tenant entity will survive and remain liable.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.